Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making
D. Coppens, Sofieke de Wilde, Henk‐Jan Guchelaar, et al.
Cytotherapy (2018) Vol. 20, Iss. 6, pp. 769-778
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Automated manufacturing of cell therapies
Alice Melocchi, Brigitte Schmittlein, Sudeshna Sadhu, et al.
Journal of Controlled Release (2025)
Open Access | Times Cited: 4
Current standards and ethical landscape of engineered tissues—3D bioprinting perspective
Muthu Parkkavi Sekar, Harshavardhan Budharaju, Allen Zennifer, et al.
Journal of Tissue Engineering (2021) Vol. 12
Open Access | Times Cited: 80
Biobridge: An Outlook on Translational Bioinks for 3D Bioprinting
Yawei Gu, Aurélien Forget, V. Prasad Shastri
Advanced Science (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 43
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions
Eline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 399-415
Open Access | Times Cited: 34
In-situ bioprinting of skin - A review
Muhammad Salman Chaudhry, Aleksander Czekanski
Bioprinting (2023) Vol. 31, pp. e00271-e00271
Closed Access | Times Cited: 12
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell–based genomic therapies and the challenges faced
Ashish O. Gupta, Melissa Azul, Senthil Velan Bhoopalan, et al.
Cytotherapy (2024) Vol. 26, Iss. 11, pp. 1411-1420
Closed Access | Times Cited: 4
Regulatory landscape and challenges in CAR-T cell therapy development in the US, EU, Japan, and India
Kirthiga Devi S S, Ramesh Joga, Saurabh Srivastava, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 201, pp. 114361-114361
Open Access | Times Cited: 4
Future trends in synthetic biology in Asia
Ning Mao, Nikhil Aggarwal, Chueh Loo Poh, et al.
Advanced Genetics (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 25
Creating a GMP Cell Processing Program: A focus on quality and regulation.
Darshan Patel, Jane Reese Koç, Folashade Otegbeye
Best Practice & Research Clinical Haematology (2025), pp. 101614-101614
Closed Access
The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time
Lorenzo Piemonti, Hanne Scholz, Dide de Jongh, et al.
Transplant International (2023) Vol. 36
Open Access | Times Cited: 9
Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries
D. Coppens, Jarno Hoekman, Marie L. De Bruin, et al.
Cytotherapy (2020) Vol. 22, Iss. 10, pp. 592-600
Open Access | Times Cited: 22
Vector Copy Distribution at a Single-Cell Level Enhances Analytical Characterization of Gene-Modified Cell Therapies
Ilaria Santeramo, Marta Bagnati, Emily Jane Harvey, et al.
Molecular Therapy — Methods & Clinical Development (2020) Vol. 17, pp. 944-956
Open Access | Times Cited: 21
A primer to gene therapy: Progress, prospects, and problems
Hidde A. Zittersteijn, Manuel A. F. V. Gonçalves, Rob C. Hoeben
Journal of Inherited Metabolic Disease (2020) Vol. 44, Iss. 1, pp. 54-71
Open Access | Times Cited: 20
Challenges for Cell-Based Medicinal Products From a Pharmaceutical Product Perspective
Dhananjay Jere, Ahmad S. Sediq, Jörg Huwyler, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 5, pp. 1900-1908
Closed Access | Times Cited: 18
Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union
Carolina Iglesias-López, Antònia Agustí, Antonio Vallano, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 14
Toward gene therapy for congenital thrombotic thrombocytopenic purpura
Charlotte Dekimpe, Elien Roose, Kazuya Sakai, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 5, pp. 1090-1099
Open Access | Times Cited: 5
Regulating Advanced Therapy Medicinal Products through the Hospital Exemption: An Analysis of Regulatory Approaches in Nine EU Countries
D. Coppens, Helga Gardarsdóttir, Marie L. De Bruin, et al.
Regenerative Medicine (2020) Vol. 15, Iss. 8, pp. 2015-2028
Open Access | Times Cited: 13
Four scenarios for the future of medicines and social policy in 2030
Hubert G. M. Leufkens, Zuzana Kusynová, Murray Aitken, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2252-2260
Open Access | Times Cited: 8
Regulatory and clinical development to support the approval of advanced therapies medicinal products in Japan
Carolina Iglesias-López, Antònia Agustí, Mercè Obach, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 7, pp. 831-842
Open Access | Times Cited: 6
On CAR-Ts, decentralized in-house models, and the hospital exception. Routes for sustainable access to innovative therapies
Luca Arnaudo
Journal of Law and the Biosciences (2022) Vol. 9, Iss. 2
Open Access | Times Cited: 6
Addressing the challenges of novel therapies in rare diseases with mechanistic perspectives: Missed opportunities or the way forward?
Janet Mifsud, Noel Cranswick
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 6, pp. 2480-2483
Open Access | Times Cited: 5
Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies
Carsten W. Lederer, Lola Koniali, Tina Buerki‐Thurnherr, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 793-793
Open Access | Times Cited: 5
Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection
Renske M.T. ten Ham, Anke M. Hövels, Olaf H. Klungel, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 2, pp. 67-71
Open Access | Times Cited: 7
Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side
Laura García-Pérez, Anita Ordas, Kirsten Canté-Barrett, et al.
Pharmaceutics (2020) Vol. 12, Iss. 6, pp. 549-549
Open Access | Times Cited: 7
Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope?
Stefanie Klaver-Flores, Hidde A. Zittersteijn, Kirsten Canté-Barrett, et al.
Frontiers in Genome Editing (2021) Vol. 2
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top